| Filed On | Filing |
|---|---|
| 14 Oct 2026 | QUARTERLY REPORT |
| 14 Jul 2026 | QUARTERLY REPORT |
| 14 Apr 2026 | QUARTERLY REPORT |
| 02 Apr 2026 |
Form 4: Levy Ira, Director
Granted 19,130 Stock Option (Right to Buy) |
| 27 Feb 2026 | ANNUAL REPORT |
| 21 Jan 2026 | SCHEDULE 13G/A |
| 02 Dec 2025 | 8-K: Submission of Matters to a Vote of Security Holders |
| 03 Nov 2025 |
Proxy statement: annual meeting on November 25, 2025
CEO pay $531K, up 27% |
| 03 Nov 2025 | SCHEDULE 13G |
| 24 Oct 2025 | PROXY STATEMENT |
| 15 Oct 2025 | QUARTERLY REPORT |
| 14 Jul 2025 | QUARTERLY REPORT |
| 02 Jun 2025 | REGISTRATION STATEMENT |
| 27 May 2025 |
Form 4: Plafker Alan, Director
Granted 30,000 Stock Option (Right to Buy) |
| 27 May 2025 |
Form 4: Lubman Steven J, Director
Disposed of 50,000 Stock Option (Right to Buy) (Grant/Award Acquisition) |
| 27 May 2025 |
Form 4: Levy Ira, Director
Granted 50,000 Stock Option (Right to Buy) |
| 27 May 2025 |
Form 4: Chariton Lawrence, Director
Disposed of 30,000 Stock Option (Right to Buy) (Grant/Award Acquisition) |
| 23 May 2025 |
Form 4: Levy Peter, Director
Granted 30,000 Stock Option (Right to Buy) |
| 23 May 2025 |
Form 4: Jacobs Gary Mark, Director
Granted 30,000 Stock Option (Right to Buy) |
| 24 Apr 2025 |
Form 4: Levy Ira, Director
Received 14,659 shares as a grant or award |
Loading...
